WallStSmart
BCDA

Biocardia Inc

NASDAQ: BCDA · HEALTHCARE · BIOTECHNOLOGY

$1.12
+12.08% today

Updated 2026-06-05

Market cap
$10.09M
P/E ratio
P/S ratio
1,985.81x
EPS (TTM)
$-0.85
Dividend yield
52W range
$1 – $2
Volume
3.2M

Biocardia Inc (BCDA) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$643000.00$1.27M$1.87M$12000.00$62000.00$268000.00$427000.00$517000.00$576000.00$479000.00$625000.00$710000.00$145000.00$1.01M$1.35M$477000.00$58000.00$0.00
Revenue growth (YoY)+97.2%+47.4%-100.0%+416.7%+332.3%+59.3%+21.1%+11.4%-16.8%+30.5%+13.6%-79.6%+600.0%+33.2%-64.7%-87.8%-100.0%
Cost of revenue$130000.00$197000.00$380000.00$3.59M$2.70M$1.06M$746000.00$690000.00$517000.00$358000.00$4000.00$640000.00$11.90M$7.73M$4.39M$505000.00
Gross profit$513000.00$1.07M$1.49M$12000.00$62000.00$268000.00$427000.00$517000.00$-170000.00$-211000.00$108000.00$352000.00$141000.00$375000.00$-10.55M$-7.25M$-4.33M$-505000.00
Gross margin79.8%84.5%79.7%100.0%100.0%100.0%100.0%100.0%-29.5%-44.1%17.3%49.6%97.2%36.9%-780.3%-1519.7%-7463.8%
R&D$215000.00$1.33M$1.00M$2.22M$1.52M$1.52M$3.33M$5.80M$8.45M$8.56M$9.81M$8.56M$8.83M$7.73M$4.39M$4.96M
SG&A$79802.00$306527.00$3.91M$5.59M$583000.00$630000.00$401000.00$259000.00$196000.00$198000.00$4.11M$3.73M$5.76M$6.00M$5.86M$5.09M$4.42M$4.39M$3.67M$3.32M
Operating income$-92804.00$-79802.00$-5.63M$-5.10M$-583000.00$-618000.00$-339000.00$9000.00$231000.00$319000.00$-7.61M$-12.40M$-14.10M$-14.21M$-15.53M$-12.63M$-11.90M$-11.64M$-8.00M$-8.28M
Operating margin-12.4%-444.2%-273.0%-5150.0%-546.8%3.4%54.1%61.7%-1320.8%-2589.8%-2256.3%-2001.8%-10709.7%-1244.3%-880.3%-2441.1%-13794.8%
EBITDA$-92804.00$-79802.00$-3.61M$-3.90M$384000.00$-618000.00$-339000.00$9000.00$231000.00$319000.00$-8.54M$-12.23M$-13.90M$-14.05M$-14.44M$-12.57M$-11.82M$-11.49M$-7.88M$-7.72M
EBITDA margin-12.4%-285.0%-208.4%-5150.0%-546.8%3.4%54.1%61.7%-1481.8%-2553.2%-2223.8%-1978.3%-9955.2%-1238.4%-874.2%-2408.2%-13584.5%
EBIT$-92804.00$-79802.00$-4.17M$-5.10M$-583000.00$-629000.00$-339000.00$9000.00$231000.00$319000.00$-8.57M$-12.31M$-13.99M$-14.60M$-15.00M$-12.63M$-11.90M$-11.57M$-7.95M$-8.23M
Interest expense$0.00$0.00$48000.00$24000.00$27000.00$25000.00$8000.00$10000.00$3000.00$3000.00$1.74M$95000.00$118000.00$112000.00$3000.00$9000.00$6000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-92804.00$-75444.00$-5.80M$-5.08M$-11.51M$9.66M$305000.00$19000.00$234000.00$322000.00$-10.31M$-12.31M$-13.99M$-14.71M$-15.00M$-12.62M$-11.91M$-11.57M$-7.95M$-8.23M
Net income growth (YoY)+18.7%-7587.8%+12.4%-126.6%+184.0%-96.8%-93.8%+1131.6%+37.6%-3301.9%-19.4%-13.6%-5.2%-2.0%+15.9%+5.6%+2.9%+31.3%-3.5%
Profit margin-11.7%-457.4%-271.7%80516.7%491.9%7.1%54.8%62.3%-1789.9%-2569.5%-2237.9%-2071.7%-10347.6%-1243.4%-881.1%-2425.8%-13700.0%

Frequently asked questions

How much free cash flow does BCDA generate?

BCDA produced $-7.44M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is BCDA's balance sheet healthy?

BCDA holds $2.50M in cash and equivalents against — in long-term debt, on $895000.00 of shareholder equity. That debt is best read against the cash flow the business throws off each year.